Publication | Open Access

Treatment of cancer‐associated venous thromboembolism: 12‐month outcomes of the placebo versus rivaroxaban randomization of the SELECT‐D Trial (SELECT‐D: 12m)

ThrombosisPulmonary EmbolismVenous DiseaseVenous ThrombosisVenous Disease TreatmentMedicineSelect‐d TrialHematologyClinical TrialsOutcomes ResearchAnticoagulantPharmacotherapyVenous ThromboembolismOncologyRadiation OncologyCancer ResearchHealth Sciences